Report cover image

Global Beta-lactam and Beta-lactamase Inhibitors Market Insights, Forecast to 2028

Publisher QYResearch Group
Published Mar 01, 2022
Length 198 Pages
SKU # QYR17054829

Description

Global Beta-lactam and Beta-lactamase Inhibitors Market Insights, Forecast to 2028
Market Analysis and Insights: Global Beta-lactam and Beta-lactamase Inhibitors Market

Due to the COVID-19 pandemic, the global Beta-lactam and Beta-lactamase Inhibitors market size is estimated to be worth US$ 27730 million in 2022 and is forecast to a readjusted size of US$ 31119 million by 2028 with a CAGR of 1.94% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Cephalosporins accounting for 26.96% of the Beta-lactam and Beta-lactamase Inhibitors global market in 2021, is projected to value US$ 8344 million by 2028.

Global Beta-lactam and Beta-lactamase Inhibitors Scope and Segment

Beta-lactam and Beta-lactamase Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-lactam and Beta-lactamase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company

Pfizer
Novartis (Sandoz)
TEVA
Merck
AbbVie (Allergan)
Sumitomo Dainippon
Hikma
Aurobindo Pharma
Wockhardt
Lupin Limited
Fresenius Kabi
B. Braun
USantibiotics
Qilu Pharmaceutical
ACS Dobfar
Nichi-Iko (Sagent)
Antibiotice

Segment by Type

Penicillins
Cephalosporins
Carbapenems
Monobactams
Combinations

Segment by Application

Oral
Intravenous

Segment by Region

North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Philippines
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Table of Contents

198 Pages
1 Study Coverage
1.1 Beta-lactam And Beta-lactamase Inhibitors Product Introduction
1.2 Market By Type
1.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028
1.2.2 Penicillins
1.2.3 Cephalosporins
1.2.4 Carbapenems
1.2.5 Monobactams
1.3 Market By Application
1.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028
1.3.2 Oral
1.3.3 Intravenous
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales Estimates And Forecasts 2017-2028
2.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Estimates And Forecasts 2017-2028
2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region: 2017 Vs 2021 Vs 2028
2.4 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region
2.4.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2022)
2.4.2 Global Sales Beta-lactam And Beta-lactamase Inhibitors By Region (2023-2028)
2.5 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region
2.5.1 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2022)
2.5.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition By Manufacturers
3.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers
3.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers (2017-2022)
3.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Manufacturers (2017-2022)
3.1.3 Global Top 10 And Top 5 Largest Manufacturers Of Beta-lactam And Beta-lactamase Inhibitors In 2021
3.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Manufacturers
3.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Manufacturers (2017-2022)
3.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Manufacturers (2017-2022)
3.2.3 Global Top 10 And Top 5 Companies By Beta-lactam And Beta-lactamase Inhibitors Revenue In 2021
3.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Price By Manufacturers (2017-2022)
3.4 Analysis Of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (Cr5 And Hhi)
3.4.2 Global Beta-lactam And Beta-lactamase Inhibitors Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.4.3 Global Beta-lactam And Beta-lactamase Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size By Type
4.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Type
4.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Sales By Type (2017-2022)
4.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Sales By Type (2023-2028)
4.1.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Type (2017-2028)
4.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Type
4.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Revenue By Type (2017-2022)
4.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Revenue By Type (2023-2028)
4.2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Type (2017-2028)
4.3 Global Beta-lactam And Beta-lactamase Inhibitors Price By Type
4.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Price By Type (2017-2022)
4.3.2 Global Beta-lactam And Beta-lactamase Inhibitors Price Forecast By Type (2023-2028)
5 Market Size By Application
5.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Application
5.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Sales By Application (2017-2022)
5.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Sales By Application (2023-2028)
5.1.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Application (2017-2028)
5.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Application
5.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Revenue By Application (2017-2022)
5.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Revenue By Application (2023-2028)
5.2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Application (2017-2028)
5.3 Global Beta-lactam And Beta-lactamase Inhibitors Price By Application
5.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Price By Application (2017-2022)
5.3.2 Global Beta-lactam And Beta-lactamase Inhibitors Price Forecast By Application (2023-2028)
6 North America
6.1 North America Beta-lactam And Beta-lactamase Inhibitors Market Size By Type
6.1.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028)
6.1.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028)
6.2 North America Beta-lactam And Beta-lactamase Inhibitors Market Size By Application
6.2.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028)
6.2.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028)
6.3 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Country
6.3.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028)
6.3.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Type
7.1.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028)
7.1.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028)
7.2 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Application
7.2.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028)
7.2.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028)
7.3 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Country
7.3.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028)
7.3.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028)
7.3.3 Germany
7.3.4 U.K.
7.3.5 France
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Type
8.1.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028)
8.1.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028)
8.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Application
8.2.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028)
8.2.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028)
8.3 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Region
8.3.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2028)
8.3.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
9 Latin America
9.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Type
9.1.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028)
9.1.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028)
9.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Application
9.2.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028)
9.2.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028)
9.3 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Country
9.3.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028)
9.3.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East And Africa
10.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Type
10.1.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028)
10.1.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028)
10.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Application
10.2.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028)
10.2.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028)
10.3 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Country
10.3.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028)
10.3.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 Uae
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description And Business Overview
11.1.3 Pfizer Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.1.4 Pfizer Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.2 Novartis (Sandoz)
11.2.1 Novartis (Sandoz) Corporation Information
11.2.2 Novartis (Sandoz) Description And Business Overview
11.2.3 Novartis (Sandoz) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.2.4 Novartis (Sandoz) Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description And Business Overview
11.3.3 Teva Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.3.4 Teva Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description And Business Overview
11.4.3 Merck Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.4.4 Merck Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.5 Abbvie (Allergan)
11.5.1 Abbvie (Allergan) Corporation Information
11.5.2 Abbvie (Allergan) Description And Business Overview
11.5.3 Abbvie (Allergan) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.5.4 Abbvie (Allergan) Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.6 Sumitomo Dainippon
11.6.1 Sumitomo Dainippon Corporation Information
11.6.2 Sumitomo Dainippon Description And Business Overview
11.6.3 Sumitomo Dainippon Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.6.4 Sumitomo Dainippon Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.7 Hikma
11.7.1 Hikma Corporation Information
11.7.2 Hikma Description And Business Overview
11.7.3 Hikma Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.7.4 Hikma Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Description And Business Overview
11.8.3 Aurobindo Pharma Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.8.4 Aurobindo Pharma Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Description And Business Overview
11.9.3 Wockhardt Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.9.4 Wockhardt Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.10 Lupin Limited
11.10.1 Lupin Limited Corporation Information
11.10.2 Lupin Limited Description And Business Overview
11.10.3 Lupin Limited Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.10.4 Lupin Limited Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Corporation Information
11.11.2 Fresenius Kabi Description And Business Overview
11.11.3 Fresenius Kabi Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.11.4 Fresenius Kabi Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.12 B. Braun
11.12.1 B. Braun Corporation Information
11.12.2 B. Braun Description And Business Overview
11.12.3 B. Braun Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.12.4 B. Braun Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.13 Usantibiotics
11.13.1 Usantibiotics Corporation Information
11.13.2 Usantibiotics Description And Business Overview
11.13.3 Usantibiotics Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.13.4 Usantibiotics Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.14 Qilu Pharmaceutical
11.14.1 Qilu Pharmaceutical Corporation Information
11.14.2 Qilu Pharmaceutical Description And Business Overview
11.14.3 Qilu Pharmaceutical Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.14.4 Qilu Pharmaceutical Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.15 Acs Dobfar
11.15.1 Acs Dobfar Corporation Information
11.15.2 Acs Dobfar Description And Business Overview
11.15.3 Acs Dobfar Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.15.4 Acs Dobfar Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.16 Nichi-iko (Sagent)
11.16.1 Nichi-iko (Sagent) Corporation Information
11.16.2 Nichi-iko (Sagent) Description And Business Overview
11.16.3 Nichi-iko (Sagent) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.16.4 Nichi-iko (Sagent) Beta-lactam And Beta-lactamase Inhibitors Products Offered
11.17 Antibiotice
11.17.1 Antibiotice Corporation Information
11.17.2 Antibiotice Description And Business Overview
11.17.3 Antibiotice Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022)
11.17.4 Antibiotice Beta-lactam And Beta-lactamase Inhibitors Products Offered
12 Market Drivers, Opportunities, Challenges Factors Analysis
12.1 Beta-lactam And Beta-lactamase Inhibitors Industry Trends
12.2 Beta-lactam And Beta-lactamase Inhibitors Market Drivers
12.3 Beta-lactam And Beta-lactamase Inhibitors Market Challenges
13 Value Chain And Sales Channels Analysis
13.1 Value Chain Analysis
13.2 Beta-lactam And Beta-lactamase Inhibitors Customers
13.3 Sales Channels Analysis
13.3.1 Sales Channels
13.3.2 Distributors
14 Research Findings And Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
 
List Of Tables
Table 1. Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 (Us$ Million)
Table 2. Penicillins Of Current And Historical Uses
Table 3. Cephalosporins Of Current Clinical Utility Or Of Historical Interest
Table 4. Major Manufacturers Of Cephalosporins
Table 5. Carbapenems Of Current Clinical Utility
Table 6. Major Manufacturers Of Carbapenems
Table 7. Carbapenems Of Current Clinical Utility
Table 8. Major Manufacturers Of Monobactams
Table 9. Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 (Us$ Million)
Table 10. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region: 2017 Vs 2021 Vs 2028 (Us$ Million)
Table 11. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2022) & (M Units)
Table 12. Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Region (2017-2022)
Table 13. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2023-2028) & (M Units)
Table 14. Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Region (2023-2028)
Table 15. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2022) & (Us$ Million)
Table 16. Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Region (2017-2022)
Table 17. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2023-2028) & (Us$ Million)
Table 18. Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Region (2023-2028)
Table 19. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers (2017-2022) & (M Units)
Table 20. Global Beta-lactam And Beta-lactamase Inhibitors Sales Share By Manufacturers (2017-2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us